MedTrace Logo

Study of CT001 in Healthy Volunteers

NCT04807335 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2021-08-24

No results posted yet for this study

Summary

A phase 1, three arms, cross over comparison study to evaluate bioavailability, pharmacokinetics and safety of intra nasal CT001 in healthy volunteers.

Conditions

  • Bioavailability

Interventions

DRUG

CT001

nasal spray

DRUG

Ketamine

iv single dose

DRUG

sufentanil

iv single dose

Sponsors & Collaborators

  • Dantrials Aps

    collaborator INDUSTRY

  • Smerud Medical Research International AS

    collaborator OTHER

  • Cessatech A/S

    lead INDUSTRY

Principal Investigators

  • Mads Werner, MD · Rigshospitalet, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-17
Primary Completion
2021-06-02
Completion
2021-06-02

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04807335 on ClinicalTrials.gov